Abraham Chachoua, MD

  • Specialty: Medical Oncology
  • Language: English
  • Phone: 212-731-5388

About Me

When I was a medical student in Melbourne, Australia, my father was diagnosed with multiple myeloma—a cancer that starts in bone marrow. During his treatment, I learned the tremendous value of communication between doctor and patient. I wanted to get the chance to deliver the best care possible to people like my father, which is what drew me to oncology. 

There were limited opportunities in the 1980s for oncologists in Australia—chemotherapy was not yet available there. So I came to NYU Langone, where chemotherapy and other modern advances in cancer treatment were available, for a research fellowship in medical oncology in 1985. When I landed in New York City, there was a tremendous sense of freedom that I’d never experienced anywhere else, and it’s still with me now. 

I specialize in the treatment of cancers of the lung and chest. I’m also conducting exciting research in immunotherapy, which helps us to enhance and harness the power of the immune system to eradicate cancer. This treatment causes fewer side effects and results in higher rates of remission.

But good patient care is just as much about art as it is science. If you color by numbers, you’ll create a nice painting, but if you instead pour your heart into it, you'll occasionally produce a masterpiece.

I embark on a journey with each patient, trying to make the road better and smoother. I spend time with patients—joking around, talking about family, and easing their pain.

Conditions and Treatments

lung cancer, mesothelioma, thymus cancer, small cell carcinoma of lung, non-small cell lung carcinoma


  • Jay and Isabel Fine Professor of Oncology, Department of Medicine
  • Professor, Department of Urology
  • Assoc Dir Cancer Services Perlmutter Cancer Center
Education and Training
  • Fellowship, Alfred Hospital, Hematology/Oncology, 1984
  • Residency, Alfred Hospital, Rotating, 1982
  • MD from Monash University, 1978

Locations and Appointments

76 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Agewell
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP Essential
  • HIP Family Health
  • HIP Medicaid
  • HIP Medicare
  • HealthSmart (WTC)
  • Healthfirst
  • Healthfirst Essential
  • Hotel Trades
  • Humana Medicare
  • Independent Care System New York
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • PHP
  • Tricare
  • UPN Elite
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Medical Oncology Associates

160 East 34th Street, 8th Floor
New York, NY 10016


Phone: 212-731-5388

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

“With our research, we aim to develop cancer treatments that cause fewer side effects.”

Abraham Chachoua, MD Medical Oncologist

My Research

Dr. Abraham Chachoua specializes in the treatment of thoracic malignancies. Originally trained in Melbourne, Australia, he came to NYU to complete a research fellowship in medical oncology and was the recipient of an American Cancer Society career development award to evaluate the role of immune modulation in the treatment of solid tumors.

He has been involved in a number of clinical trials for the treatment of non small cell lung cancer.

Dr. Chachoua has a particular interest in the study of novel targeted therapies, how to use them earlier in the course of the illness and how to combine them with conventional chemotherapy for the treatment of advanced thoracic cancers. Among other interests he also attempts to use unique approaches for the integration of multimodality approaches for the treatment of locally advanced lung cancer.


  • Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma

    Pass, Harvey I; Goparaju, Chandra; Espin-Garcia, Osvaldo; Donington, Jessica; Carbone, Michele; Patel, Devalben; Chen, Zhuo; Feld, Ronald; Cho, John; Gadgeel, Shirish; Wozniak, Antoinette; Chachoua, Abraham; Leighl, Natasha; Tsao, Ming-Sound; de Perrot, Marc; Xu, Wei; Liu, Geoffrey
    Journal of thoracic oncology. 2016 Feb 21. 11 (6): 900-909

  • RICTOR amplification defines a novel subset of lung cancer patients who may benefit from treatment with mTOR1/2 inhibitors

    Cheng, Haiying; Zou, Yiyu; Ross, Jeffrey S; Wang, Kai; Liu, Xuewen; Halmos, Balazs; Ali, Siraj M; Liu, Huijie; Verma, Amit; Montagna, Cristina; Chachoua, Abraham; Goel, Sanjay; Schwartz, Edward L; Zhu, Changcheng; Shan, Jidong; Yu, Yiting; Gritsman, Kira; Yelensky, Roman; Lipson, Doron; Otto, Geoff; Hawryluk, Matthew; Stephens, Philip J; Miller, Vincent A; Piperdi, Bilal; Perez-Soler, Roman
    Cancer discovery. 2015 Sep 14. 5 (12): 1262-1270

  • Abscopal Responses in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated on a Phase 2 Study of Combined Radiation Therapy and Ipilimumab: Evidence for the In Situ Vaccination Hypothesis of Radiation [Meeting Abstract]

    Golden, EB; Chachoua, A; Fenton-Kerimian, MB; Demaria, S; Formenti, SC
    International journal of radiation oncology biology physics. 2015 NOV 1. 93 (3): S66-S67

Read All Publications (83)